β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model

被引:16
|
作者
Moran-Jones, Kim [1 ]
Ledger, Anita [1 ]
Naylor, Matthew J. [1 ,2 ,3 ]
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
[2] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia
来源
SCIENTIFIC REPORTS | 2012年 / 2卷
基金
英国医学研究理事会;
关键词
BETA(1A) INTEGRIN EXPRESSION; ALPHA(2)BETA(1) INTEGRIN; TERMINAL DIFFERENTIATION; 3-DIMENSIONAL CULTURES; CELL-PROLIFERATION; TRANSGENIC MOUSE; MAMMARY-GLAND; IN-VIVO; GROWTH; PROTEIN;
D O I
10.1038/srep00526
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
beta 1 integrin regulates the response of both normal and cancer cells to their local environment. Although mis-localised in prostate cancer, the role beta 1 integrin plays in prostate development and carcinogenesis remains unknown. To assess the role of beta 1 integrin in vivo, we conditionally deleted beta 1 integrin from prostate epithelium and subsequently crossed these mice to the TRAMP prostate carcinogenesis model. Deletion of beta 1 integrin following castration and subsequent androgen supplementation resulted in an expansion of the p63-positive basal cell population and decreased differentiation. Consistent with these findings, deletion of beta 1 integrin in TRAMP mice decreased animal survival, decreased retention of normal prostate morphology, increased the percentage of tissue with poorly differentiated carcinoma, and increased cell proliferation. This study demonstrates that beta 1 integrin regulates several aspects of normal prostate development and in contrast to its role in several other tissues, its loss is associated with increased rates of prostate tumour progression.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [21] Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer - Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice
    Williams, TM
    Hassan, GS
    Li, JW
    Cohen, AW
    Medina, F
    Frank, PG
    Pestell, RG
    Di Vizio, D
    Loda, M
    Lisanti, MP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) : 25134 - 25145
  • [22] Theaflavins inhibit prostate carcinogenesis in the tramp mouse model
    Thorpe, J
    Jain, S
    Marczylo, T
    Gescher, A
    Steward, W
    Mellon, JK
    JOURNAL OF UROLOGY, 2006, 175 (04): : 81 - 81
  • [23] Molecular markers of progression in tramp and human prostate cancer.
    Gingrich, JR
    Wheeler, TM
    Greenberg, NM
    JOURNAL OF UROLOGY, 1998, 159 (05): : 4 - 4
  • [24] LYCOPENE AND CHEMOPREVENTION OF PROSTATE CANCER IN THE TRAMP MODEL
    Konijeti, Ramdev
    Henning, Susanne M.
    Moro, Aune
    Sheikh, Ahmed
    Elashoff, David
    Shapiro, Ari
    Cohen, Pinchas
    Heber, David
    Aronson, William J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 515 - 515
  • [25] Rhamnetin inhibits prostate cancer progression in an autochthonous mouse prostate cancer model
    Oak, Christine
    Bhaskaran, Natarajan
    Gupta, Sanjay
    Shukla, Sanjeev
    CANCER RESEARCH, 2015, 75
  • [26] Chemoprevention of Prostate Cancer with Lycopene in the TRAMP Model
    Konijeti, Ramdev
    Henning, Susanne
    Moro, Aune
    Sheikh, Ahmed
    Elashoff, David
    Shapiro, Ari
    Ku, Melvin
    Said, Jonathan W.
    Heber, David
    Cohen, Pinchas
    Aronson, William J.
    PROSTATE, 2010, 70 (14): : 1547 - 1554
  • [27] Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?
    Xu, Hua
    Hu, Meng-bo
    Bai, Pei-de
    Zhu, Wen-hui
    Ding, Qiang
    Jiang, Hao-wen
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (12) : 2327 - 2334
  • [28] X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model
    C Hwang
    K A Oetjen
    D Kosoff
    K J Wojno
    M A Albertelli
    R L Dunn
    D M Robins
    K A Cooney
    C S Duckett
    Cell Death & Differentiation, 2008, 15 : 831 - 840
  • [29] Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches
    Kido, Larissa Akemi
    Lamas, Celina de Almeida
    Marostica, Mario Roberto, Jr.
    Alves Cagnon, Valeria Helena
    LIFE SCIENCES, 2019, 217 : 141 - 147
  • [30] Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model
    Wu, GJ
    Fu, PP
    Chiang, CF
    Huss, WJ
    Greenberg, NM
    Wu, MWH
    JOURNAL OF UROLOGY, 2005, 173 (05): : 1778 - 1783